Vogenx, Inc., 2026-01-07
An SEC Form D private-offering notice from Raleigh, NC, a $5,000,000 filer-stated offering target in Biotech. Filed 2026-01-07. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing therapies for metabolic and gastrointestinal disorders, including its lead SGLT1 inhibitor candidate mizagliflozin for post-bariatric hypoglycemia and gastroparesis.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Flourish Health & Nutrition Partners, Inc., 2026-01-21, $250K, Raleigh, NC
- Immorta Bio, Inc., 2026-01-08, $500K, Miami Beach, FL
- Old Well Labs, Inc., 2026-01-20, $4M, Charlotte, NC
- Matthias Therapeutics, LLC, 2026-01-07, $500K, Basking Ridge, NJ
- Stork Exchange, Inc., 2026-01-20, $2M, Charlotte, NC
- Fitness Fingerprint Therapeutics, Inc., 2026-01-07, $18.8M, Richmond, VA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.